Sol Atriyal Apendiks Kapama Sonrası Rezidüel Kaçak Yönetimi

Benjamin EJ, Muntner P, Alonso A, et al; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2019 update: a report from the American Heart Association. Circulation. 2019

Furie KL, Goldstein LB, Albers GW, et al; American Heart Association Stroke Council; Council on Quality of Care and Outcomes Research; Council on Cardiovascular Nursing;Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: a science advisory for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012

Hornung M, Gafoor S, Id D, et al. Catheter-based closure of residual leaks after percutaneous occlusion of the left atrial appendage. Catheter Cardiovasc Interv. 2016 Jun; 87(7): 1324-1330

Naeini PS, Rasekh A. A review of clinical trials on LARIAT device. J Atr Fibrillation. 2015 Oct 31; 8(3): 1317

O’Brien EC,Holmes DN,Ansell JE,et al.Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.Am Heart J. 2014; 167

Lakkireddy D, Thaler D, Ellis CR, Swarup V, Sondergaard L, Carroll J et al. Amplatzer Amulet left atrial appendage occluder versus Watchman device for stroke prophylaxis (Amulet IDE): a randomized, controlled trial. Circulation 2021;144:1543–52.

Saw J, Holmes DR, Cavalcante JL, Freeman JV, Goldsweig AM, Kavinsky CJ et al. SCAI/ HRS expert consensus statement on transcatheter left atrial appendage closure. JACC Cardiovasc Interv 2023;16:1384–400

Osmancik P, Herman D, Neuzil P, Hala P, Taborsky M, Kala P, et al Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation. J Am Coll Cardiol. 2020 Jun 30;75(25):3122–35.

Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, et al Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009 Aug 15;374(9689):534–42.

Reddy VY, Doshi SK, Sievert H, Buchbinder M, Neuzil P, Huber K, et al Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman left atrial appendage system for embolic protection in patients with atrial fibrillation) trial. Circulation. 2013 Feb 12;127(6):720–9.

Holmes DR Jr, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, et al Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014 Jul 8;64(1):1–12.

Reddy VY, Sievert H, Halperin J, Doshi SK, Buchbinder M, Neuzil P, et al Percutaneous left atrial appendage closure vs. warfarin for atrial fibrillation: a randomized clinical trial. JAMA. 2014 Nov 19;312(19):1988–98.

Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S. Safety of percutaneous left atrial appendage closure: results from the Watchman left atrial appendage system for embolic protection in patients with AF (PROTECT AF) clinical trial and the continued access registry. Circulation. 2011 Feb 1;123(4):417–24.

Holmes DR Jr, Reddy VY, Gordon NT, Delurgio D, Doshi SK, Desai AJ, et al Long-term safety and efficacy in continued access left atrial appendage closure registries. J Am Coll Cardiol. 2019 Dec 10;74(23):2878–89.

Reddy VY, Möbius-Winkler S, Miller MA, Neuzil P, Schuler G, Wiebe J, et al Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). J Am Coll Cardiol. 2013 Jun 25;61(25):2551–6.

Landmesser U, Tondo C, Camm J, Diener HC, Paul V, Schmidt B, et al Left atrial appendage occlusion with the AMPLATZER Amulet device: one-year follow-up from the prospective global Amulet observational registry. EuroIntervention. 2018 Aug 3;14(5):e590–e97.

Hildick-Smith D, Landmesser U, Camm AJ, Diener HC, Paul V, Schmidt B, et al Left atrial appendage occlusion with the Amplatzer Amulet device: full results of the prospective global observational study. Eur Heart J. 2020 Aug 7;41(30):2894–901

Su P, McCarthy KP, Ho SY. Occluding the left atrial appendage: anatomical considerations. Heart. 2008 Sep;94(9):1166–70.

Fastner C, Nienaber CA, Park JW, Brachmann J, Zeymer U, Goedde M et al. Impact of left atrial appendage morphology on indication and procedural outcome after interventional occlusion: results from the prospective multicentre German LAARGE registry. EuroIntervention 2018;14:151–7.

Raphael CE,Friedman PA,Saw J,Pislaru SV,Munger TM,Holmes Jr.,Residual leaks following percutaneous left atrial appendage occlusion: assessment and management implications.EuroIntervention. 2017; 13

Gianni C,Di Biase L,Trivedi C,et al.Clinical implications of leaks following left Atrial appendage ligation with the LARIAT device.JACC: Cardiovascular Interventions. 2016; 9

Delgado V, Bax JJ. Atrial functional mitral regurgitation: from mitral annulus dilatation to insufficient leaflet remodeling. Circulation: Cardiovascular Imaging. 2017;10(3).

Afzal MR, Gabriels JK, Jackson GG, Chen L, Buck B, Campbell S et al. Temporal changes and clinical implications of delayed peridevice leak following left atrial appendage closure. JACC Clin Electrophysiol 2022;8:15–25.

Dukkipati SR, Holmes DR Jr, Doshi SK, Kar S, Singh SM, Gibson D et al. Impact of peridevice leak on 5-year outcomes after left atrial appendage closure. J Am Coll Cardiol 2022;80:469–83.

Viles-Gonzalez JF, Kar S, Douglas P, Dukkipati S, Feldman T, Horton R et al. The clinical impact of incomplete left atrial appendage closure with the Watchman device in patients with atrial fibrillation: a PROTECT AF (percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation) substudy. J Am Coll Cardiol 2012;59:923–9.

Hildick-Smith D, Landmesser U, Camm AJ, Diener HC, Paul V, Schmidt B et al. Left atrial appendage occlusion with the Amplatzer Amulet device: full results of the prospective global observational study. Eur Heart J 2020;41:2894–901.

Urena M, Rodés-Cabau J, Freixa X, Saw J, Webb JG, Freeman M, Horlick E, Osten M, Chan A, Marquis JF, Champagne J, Ibrahim R. Percutaneous left atrial appendage closure with the AMPLATZER cardiac plug device in patients with nonvalvular atrial fibrillation and contraindications to anticoagulation therapy. J Am Coll Cardiol. 2013;62:96-102.

Saw J, Tzikas A, Shakir S, Gafoor S, Omran H, Nielsen-Kudsk JE et al. Incidence and clinical impact of device-associated thrombus and peri-device leak following left atrial appendage closure with the Amplatzer cardiac plug. JACC Cardiovasc Interv 2017;10:391–9.

Price MJ, Ellis CR, Nielsen-Kudsk JE, Thaler D, Gupta N, Koulogiannis K et al. Peridevice leak after transcatheter left atrial appendage occlusion: an analysis of the Amulet IDE trial. JACC Cardiovasc Interv 2022;15:2127–38.

Korsholm K, Jensen JM, Nørgaard BL, Samaras A, Saw J, Berti S, Tzikas A, Nielsen-Kudsk JE. Peridevice Leak Following Amplatzer Left Atrial Appendage Occlusion: Cardiac Computed Tomography Classification and Clinical Outcomes. JACC Cardiovasc Interv. 2021;14:83-93.

Goitein O, Fink N, Hay I, Di Segni E, Guetta V, Goitein D, Brodov Y, Konen E, Glikson M. Cardiac CT Angiography (CCTA) predicts left atrial appendage occluder device size and procedure outcome. Int J Cardiovasc Imaging. 2017;33:739-747.

Saw J, Fahmy P, Spencer R, Prakash R, McLaughlin P, Nicolaou S, Tsang M. Comparing Measurements of CT Angiography, TEE, and Fluoroscopy of the Left Atrial Appendage for Percutaneous Closure. J Cardiovasc Electrophysiol. 2016;27:414-422.

Saw J,Fahmy P,DeJong P,et al.Cardiac CT angiography for device surveillance after endovascular left atrial appendage closure European Heart Journal – Cardiovascular Imaging. 2015; 16

Granier M,Laugaudin G,Massin F et al.Occurrence of incomplete endothelialization causing residual permeability after left atrial appendage closureJ Invasive Cardiol. 2018; 30: 245-250

Nguyen A,Gallet R,Riant Eet al. Peridevice leak after left atrial appendage closure: incidence, risk factors, and clinical impact.Cana J Cardiol. 2019; 35 (doi:10.1016/j.cjca.2018.12.022.): 405-412

Korsholm K, Jensen JM, Nørgaard BL, Nielsen-Kudsk JE. Temporal changes and clinical significance of peridevice leak following left atrial appendage occlusion with Amplatzer devices. Catheter Cardiovasc Interv. 2022;99:2071-2079.

Alkouli M, Du C, Killu A, Simard T, Noseworthy PA, Friedman PA, Curtis JP, Freeman JV, Holmes DR. Clinical Impact of Residual Leaks Following Left Atrial Appendage Occlusion: Insights From the NCDR LAAO Registry. JACC Clin Electrophysiol. 2022;8:766-778.

Tzikas A,Shakir S,Gafoor S et al.Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug.EuroIntervention. 2016; 11

Alkhouli M, Alqahtani F, Kazienko B, Olgers K, Sengupta PP. Percutaneous closure of peridevice leak after left atrial appendage occlusion. JACC Cardiovasc Interv. 2018 Jun 11;11(11):e83–5.

Alkhouli M, Chaker Z, Al-Hajji M, Sengupta PP. Management of peridevice leak following left atrial appendage occlusion. JACC Clin Electrophysiol. 2018 Jul;4(7):967–9.

Della Rocca DG, Horton RP, Di Biase L, Bassiouny M, Al-Ahmad A, Mohanty S, Gasperetti A et al.First Experience of Transcatheter Leak Occlusion With Detachable Coils Following Left Atrial Appendage Closure. JACC Cardiovasc Interv. 2020;13:306-319.